FIELD: organic chemistry, chemical technology. SUBSTANCE: invention describes sulfonamides of the general formula (I) where X means C3-C9-alkylene group; R2 means H or C1-C3-alkyl; R11 means H or C1-C3- alkyl; p = 0 or 1; q = 0-3; R12 means phenyl or naphthyl optionally substituted with halogen atom, methoxy-group or trifluoromethyl-group, 4-biphenyl, cyclohexyl or adamantyl and R13 is taken independently among H, methyl and phenyl, and to methods of their synthesis. Compounds of the formula (I) are ligands of H3- receptors of histamine and can be used as sedative agents, sleep regulators, anticonvulsant agents, antidepressants and modulators of brain blood circulation and for treatment of patients with asthma and irritable bowel syndrome also. EFFECT: improved method of synthesis, valuable medicinal properties. 10 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | 2002 |
|
RU2304438C2 |
METHOD OF SYNTHESIS OF UNSATURATED ACID AMIDES | 1989 |
|
RU2010025C1 |
DERIVATIVES OF 4-MERCAPTOPYRROLIDINE AS INHIBITORS OF FARNESYLTRANSFERASE | 1996 |
|
RU2191773C2 |
DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2198878C2 |
PYRROLOINDOLES, PYRIDINEINDOLES AND AZEPINOINDOLES AS 5-HT AGONISTS | 1999 |
|
RU2232162C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2182574C2 |
INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
INDOLE DERIVATIVES, THEIR OPTICAL ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2095360C1 |
AMIDINE DERIVATIVES | 1992 |
|
RU2130014C1 |
Authors
Dates
2002-05-27—Published
1997-02-10—Filed